These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2964672)

  • 21. Low doses of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)-tetralin (8-OH DPAT) increase ethanol intake.
    Tomkins DM; Higgins GA; Sellers EM
    Psychopharmacology (Berl); 1994 Jun; 115(1-2):173-9. PubMed ID: 7862892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of the novel anxiolytics gepirone, buspirone and ipsapirone on free feeding and on feeding induced by 8-OH-DPAT.
    Gilbert F; Dourish CT
    Psychopharmacology (Berl); 1987; 93(3):349-52. PubMed ID: 2893412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dextrofenfluramine, but not 8-OH-DPAT affects the decrease in food consumed by rats submitted to physical exercise.
    Chaouloff F; Danguir J; Elghozi JL
    Pharmacol Biochem Behav; 1989 Feb; 32(2):573-6. PubMed ID: 2524844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of metergoline and 8-OH-DPAT injections into arcuate nucleus and lateral hypothalamic area on feeding in female rats during the estrous cycle.
    Steffens SM; da Cunha IC; Beckman D; Lopes AP; Faria MS; Marino-Neto J; Paschoalini MA
    Physiol Behav; 2008 Oct; 95(3):484-91. PubMed ID: 18694771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence that the hyperphagic response to 8-OH-DPAT is mediated by 5-HT1A receptors.
    Hutson PH; Dourish CT; Curzon G
    Eur J Pharmacol; 1988 Jun; 150(3):361-6. PubMed ID: 2970974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Partial postsynaptic 5-HT1A agonist properties of the novel stereoselective 8-OH-DPAT analogue (+)cis-8-hydroxy-1-methyl-2-(di-n-propylamino)tetralin, (+)ALK-3.
    Hjorth S; Sharp T; Hacksell U
    Eur J Pharmacol; 1989 Nov; 170(3):269-74. PubMed ID: 2533557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular response to 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) in the rat: site of action and pharmacological analysis.
    Fozard JR; Mir AK; Middlemiss DN
    J Cardiovasc Pharmacol; 1987 Mar; 9(3):328-47. PubMed ID: 2437400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the cardiovascular effects of the 5-HT1A receptor agonist flesinoxan with that of 8-OH-DPAT in the rat.
    Dreteler GH; Wouters W; Saxena PR
    Eur J Pharmacol; 1990 May; 180(2-3):339-49. PubMed ID: 2142096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Behavioural effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in monkeys.
    Mizuta E; Yamaguchi M; Kuno S
    Eur J Pharmacol; 1990 Mar; 178(1):125-7. PubMed ID: 2139614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of 5-HT1A- and alpha 2-receptors in the decreased 5-hydroxytryptamine release and metabolism in rat suprachiasmatic nucleus after intravenous 8-hydroxy-2-(n-dipropylamino) tetralin.
    Marsden CA; Martin KF
    Br J Pharmacol; 1986 Oct; 89(2):277-86. PubMed ID: 2430656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential anxiolytic properties of 8-hydroxy-2-(di-n-propylamino)tetralin, a selective serotonin 1A receptor agonist.
    Carli M; Samanin R
    Psychopharmacology (Berl); 1988; 94(1):84-91. PubMed ID: 2894704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 8-OH-DPAT increases corticosterone but not other 5-HT1A receptor-dependent responses more in females.
    Haleem DJ; Kennett GA; Whitton PS; Curzon G
    Eur J Pharmacol; 1989 May; 164(3):435-43. PubMed ID: 2527755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of the 5-HT1A agonist 8-OH-DPAT on food intake in food-deprived rats.
    Ebenezer IS
    Neuroreport; 1992 Nov; 3(11):1019-22. PubMed ID: 1482760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Central 5-HT1A receptors and the mechanism of the central hypotensive effect of (+)8-OH-DPAT, DP-5-CT, R28935, and urapidil.
    Doods HN; Boddeke HW; Kalkman HO; Hoyer D; Mathy MJ; van Zwieten PA
    J Cardiovasc Pharmacol; 1988 Apr; 11(4):432-7. PubMed ID: 2453746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective increase in carbohydrate intake by rats treated with 8-hydroxy-2-(di-n-propylamino)-tetraline or buspirone.
    Luo SQ; Ransom T; Li ET
    Life Sci; 1990; 46(23):1643-8. PubMed ID: 2141379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Marked increases in plasma catecholamine concentrations precede hypotension and bradycardia caused by 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) in conscious rats.
    Bagdy G; Szemeredi K; Murphy DL
    J Pharm Pharmacol; 1989 Apr; 41(4):270-2. PubMed ID: 2568470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The long-term effects of 8-hydroxy-2-(di-n-propyl-amino)tetralin (8-OH-DPAT) on copulatory and exploratory behaviour in male rats.
    Johansson CE; Meyerson BJ; Höglund AU
    Eur J Pharmacol; 1990 Mar; 178(1):1-9. PubMed ID: 2139613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 8-Hydroxy-2-(di-n-propylamino)tetralin, a 5-HT1A receptor agonist, impairs performance in a passive avoidance task.
    Carli M; Tranchina S; Samanin R
    Eur J Pharmacol; 1992 Feb; 211(2):227-34. PubMed ID: 1535320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of the putative 5-HT1A receptor agonist 8-OH-2-(di-n-propylamino)tetralin on nociceptive sensitivity in mice.
    Fasmer OB; Berge OG; Post C; Hole K
    Pharmacol Biochem Behav; 1986 Oct; 25(4):883-8. PubMed ID: 2947249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discriminative stimulus properties of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH DPAT).
    Glennon RA
    Pharmacol Biochem Behav; 1986 Jul; 25(1):135-9. PubMed ID: 2944129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.